Casdin Capital, LLC bought WGS
June 5, 2026 · Form 4 insider transaction
Casdin Capital, LLC bought 50,000 shares of GeneDx Holdings Corp. at $52.86 per share, a transaction worth $2.64M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$52.86
Total value
$2.64M
InsiderCasdin Capital, LLC
Role—
CompanyGeneDx Holdings Corp. (WGS)
SecurityClass A Common Stock, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateJune 5, 2026
Filing dateJune 8, 2026
Shares owned after3,707,164
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The securities are owned directly by the Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.